Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | 1,121,604 | reported | 01 Jul 2024 | tx 13+13,562,969−47,702 |
| DAVITA INC. | 120,000 | reported | 09 Sept 2013 | tx 1+120,000 |
| Regulus Therapeutics Inc. | 75,000 | reported | 11 Dec 2012 | tx 1+75,000 |
| Black Diamond Therapeutics, Inc. | 30,550 | reported | 12 Jun 2025 | tx 8+174,346−156,297 |
| Stoke Therapeutics, Inc. | 29,747 | reported | 03 Jun 2025 | tx 6+119,032 |
| TCR2 THERAPEUTICS INC. | 0 | reported | 01 Jun 2023 | tx 56+2,808,686−2,847,165 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 30,550 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | Stoke Therapeutics, Inc. | 29,747 | 0.00 USD | deriv |
| 01 Jul 2024 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,121,604 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Stoke Therapeutics, Inc. | 7,639 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 30,550 | 0.00 USD | deriv |
| 10 Jul 2023 | SALE | Adaptimmune Therapeutics PLC | 47,702 | 0.91 USD | |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 2,715,816 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 57,846 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 3,568,026 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 359,700 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,251,966 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 736,548 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 2,158,776 | 0.00 USD | deriv |
| 03 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 981,463 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Stoke Therapeutics, Inc. | 19,441 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 132,730 | — | |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 138,871 | — | |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 132,729 | — | |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 305,800 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 138,031 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 433,037 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 39,681 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 238,008 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 3,241 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 15,120 | 0.00 USD | deriv |